Sign inJoin waitlistJoin the waitlist

Muhamed Baljevic

Physician · Vanderbilt University Medical Center

Credentials: · · · · · ·

History

Vanderbilt University Medical Center
2021–Present

Hematology and Medical Oncology
2014–2017
Internal Medicine
New York Presbyterian Hospital
2011–2014
Weill Cornell Medical College in Qatar
2006–2010

Research

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
Journal of Clinical Investigation · 2008 · 730 citations
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice
Nature Medicine · 2010 · 279 citations
Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia
Cancer Cell · 2015 · 207 citations

Douglas Sborov
14 papers
Natalie Callander
14 papers
Shaji Kumar
11 papers
Thomas Martin
10 papers
Jens Hillengass
9 papers
Yubin Kang
9 papers
Caitlin Costello
8 papers
CH
Carol Huff
8 papers
EC
Erica Campagnaro
8 papers
JO
James Omel
8 papers
Jorge Castillo
8 papers
Kelly Godby
8 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $803.2K · Vanderbilt University Medical Center
1998–2027

Clinical trials

Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
Principal investigator · Terminated · Phase 1, Phase 2
University of Nebraska
2018–2021
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2019–2029